Serum matrix metalloproteinase‐7, Syndecan‐1, and <scp>CA</scp> 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
Due to its high sensitivity, this biomarker panel has the potential to rule out PDAC in suspected cases.
Authors
- Idan Levy (ORCID: https://orcid.org/0000-0002-3797-9756)
- Miri Yavzori
- Doron Yablecovitch (ORCID: https://orcid.org/0000-0001-6191-9270)
- Ella Fudim
- Revital Dvir
- Emad Sakhnini
- Maria Raitses‐Gurevich (ORCID: https://orcid.org/0000-0002-5763-224X)
- Moshe Nadler (ORCID: https://orcid.org/0000-0003-4972-3229)
- Talia Golan (ORCID: https://orcid.org/0000-0001-5939-7012)
- Maor Lahav
- Ido Laish (ORCID: https://orcid.org/0000-0003-0324-9998)
- Talia Saker
- Orit Picard
- Moran Tardio Duchan
- Alon Lang
- Biana Freitz
- Limor Selinger
- Sandra Neuman
- Shomron Ben‐Horin
Institutions
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
- Shalvata Mental Health Center (IL)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/cam4.70144
- Citations
- 5
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.41